MIRAJI ER 500MG TAB C30 PICOSULFATO DE SODIO 100.00 MG PRINCIPIO ACTIVO: MEBENDAZOL - QUINFAMIDA

Description

PRINCIPIO ACTIVO: MEBENDAZOL - QUINFAMIDA

Pertuzumab 420 mg / 14 mL

Dosis usual: 150 mg una vez al día

Mejora de la movilidad articular

MIRAJI ER 500MG TAB C30 PICOSULFATO DE SODIO 100.00 MG PRINCIPIO ACTIVO: MEBENDAZOL - QUINFAMIDAValproato semisdico 500 MG

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy